OncoHost Unveils Exciting Advances in Plasma Proteomics for NSCLC at ISLB 2025 OncoHost showcases two innovative studies on plasma proteomics for non-small cell lung cancer monitoring and prediction at ISLB 2025, highlighting a transformative approach.

OncoHost Unveils Exciting Advances in Plasma Proteomics for NSCLC at ISLB 2025 #Israel #OncoHost #NSCLC #Binyamina #PROphetNSCLC

OncoHost's PROphetNSCLC Test Now Available for Clinical Use in New York OncoHost has secured a New York State laboratory permit, enabling the use of its innovative PROphetNSCLC test, enhancing precision oncology access.

OncoHost's PROphetNSCLC Test Now Available for Clinical Use in New York #USA #New_York #OncoHost #Precision_Oncology #PROphetNSCLC